Incubator finds $30M in atypical biotech territory

Incubator finds M in atypical biotech territory
Yet the Texas city is among dozens across the U.S. with ambitions to become biotech players, with officials willing to lure companies with incentives. It also boasts a relatively cheap cost of living compared to biotech hot spots on the East and West …
Read more on FierceBiotech

FDA readies final decisions on four big biotech drugs
The federal spending cutbacks required by sequestration may have added a big question mark to every FDA deadline on the schedule, but there are four big developers holding their breath right now in anticipation of a formal marketing decision on their …
Read more on FierceBiotech

Extended Declines Could Be in the Cards for VIVUS, Inc. (VVUS)
Over the past year, VIVUS shares are down 44.4%, compared to gains of 29.4% for the iShares NASDAQ Biotechnology Index (IBB), and surge of 51.2% for the Market Vectors Biotech (BBH) ETF. A look at the charts shows the stock remains pinned beneath …
Read more on Forbes

Leave a Reply